APA (7th ed.) Citation

ARK, M., J, Y., MA, P., CL, F., MJ, R., CL, E., . . . J, T. (2024). Chondroitin sulfate proteoglycan 4 increases invasion of recessive dystrophic epidermolysis bullosa-associated cutaneous squamous cell carcinoma by modifying transforming growth factor-β signalling. The British journal of dermatology, 192(1), 104. https://doi.org/10.1093/bjd/ljae295

Chicago Style (17th ed.) Citation

ARK, Macaulay, et al. "Chondroitin Sulfate Proteoglycan 4 Increases Invasion of Recessive Dystrophic Epidermolysis Bullosa-associated Cutaneous Squamous Cell Carcinoma by Modifying Transforming Growth Factor-β Signalling." The British Journal of Dermatology 192, no. 1 (2024): 104. https://doi.org/10.1093/bjd/ljae295.

MLA (9th ed.) Citation

ARK, Macaulay, et al. "Chondroitin Sulfate Proteoglycan 4 Increases Invasion of Recessive Dystrophic Epidermolysis Bullosa-associated Cutaneous Squamous Cell Carcinoma by Modifying Transforming Growth Factor-β Signalling." The British Journal of Dermatology, vol. 192, no. 1, 2024, p. 104, https://doi.org/10.1093/bjd/ljae295.